Abstract
Treatments for non-Hodgkin's lymphomas vary widely. Because all treatments are not useful to all patients, the non-Hodgkin's lymphomas must be divided into clinically relevant subgroups. Previous systems used to subdivide the non-Hodgkin's lymphomas were based on morphology. Later systems added immunologic subgrouping. The International Lymphoma Study Group recently has proposed that lymphomas be grouped as clinical-pathologic entities. Diagnoses based on this system were much more accurate than those using previous systems, but much work remains to be done in the classification of these cancers.

This publication has 0 references indexed in Scilit: